Real world incidence of immune-related side effects to ipilimumab/nivolumab in kidney cancer patients
A recent study published in Journal of Clinical Medicine this [...]
Association of immune-related adverse events and outcomes in kidney cancer
Previous studies have shown that cancer patients who experience immune-related [...]
Patients with autoimmune disorders have more immune-related side effects to immunotherapy
A study published in The Oncologist recently shows that patients [...]
Immunotherapy for the treatment of metastatic sarcomatoid kidney cancer
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive form of [...]
Managing immune-related adverse events
In these video interviews, Dr Eric Jonasch from MD Anderson [...]
Checkpoint inhibitor re-challenge after immune-related adverse events
Immunotherapy has revolutionised treatment in many cancers, including renal cell [...]
Survivorship and immune checkpoint inhibitors
In a study reported in the August issue of the [...]
Long term follow-up of immune-related adverse events in cancer survivors
In this study carried out at a single hospital 217 [...]
Immune-related adverse events and clinical outcome in kidney cancer treated with nivolumab
In a paper published in Clinical Genitourinary Cancer the link [...]
Safety and efficacy of restarting immune checkpoint inhibitors after immune-related adverse events
Immune checkpoint inhibitors can cause a number of immune-related adverse [...]
